• レポートコード:20QY06-00521 • 出版社/出版日:QYResearch / 2020年6月2日 ※2024年版があります。お問い合わせください。 • レポート形態:英文、PDF、139ページ • 納品方法:Eメール(受注後2~3営業日) • 産業分類:化学・材料 |
Single User | ¥600,000 (USD4,000) | ▷ お問い合わせ |
Multi User | ¥900,000 (USD6,000) | ▷ お問い合わせ |
Enterprise License | ¥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社の当調査資料では、γ-アミノ酪酸(GABA)のグローバル市場について種類別(化学合成、生物発酵)、用途別(医薬品、食品・飲料、動物飼料、その他)、地域別(北米、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・γ-アミノ酪酸(GABA)市場の概要 ・世界の主要地域別γ-アミノ酪酸(GABA)市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のγ-アミノ酪酸(GABA)市場規模2015-2026:種類別(化学合成、生物発酵) ・世界のγ-アミノ酪酸(GABA)市場規模2015-2026:用途別(医薬品、食品・飲料、動物飼料、その他) ・γ-アミノ酪酸(GABA)の北米市場規模2015-2020 ・γ-アミノ酪酸(GABA)のヨーロッパ市場規模2015-2020 ・γ-アミノ酪酸(GABA)の中国市場規模2015-2020 ・γ-アミノ酪酸(GABA)の日本市場規模2015-2020 ・γ-アミノ酪酸(GABA)の東南アジア市場規模2015-2020 ・γ-アミノ酪酸(GABA)のインド市場規模2015-2020 ・主要プレイヤーの企業情報:事業概要・売上・企業動向 (Pharma Foods International、Sekisui Chemical、Zhejiang YiWan Biolabs、Shanghai Richen、Guangdong Luckerkong Biotech、Tianjin Shijitianlong Biotech、Ningxiang Jiayuan Biology Technology、Zhejiang Tianrui Chemical、Taizhou Xinyou Pharmaceutical & Chemical) ・γ-アミノ酪酸(GABA)の製造コスト分析 ・販売チャネル、流通業者、顧客 ・γ-アミノ酪酸(GABA)の市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global GABA (CAS 56-12-2) Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global GABA (CAS 56-12-2) market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
GABA (γ-aminobutyric acid) is a four carbon non-protein amino acid that is widely distributed in plants, animals and microorganisms. As a metabolic product of plants and microorganisms produced by the decarboxylation of glutamic acid, GABA functions as an inhibitory neurotransmitter in the brain that directly affects the personality and the stress management. A wide range of traditional foods produced by microbial fermentation contain GABA, in which GABA is safe and eco-friendly, and also has the possibility of providing new health-benefited products enriched with GABA. Synthesis of GABA is catalyzed by glutamate decarboxylase, therefore, the optimal fermentation condition is mainly based on the biochemical properties of the enzyme. Major GABA producing microorganisms are lactic acid bacteria (LAB), which make food spoilage pathogens unable to grow and act as probiotics in the gastrointestinal tract.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the GABA (CAS 56-12-2) market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the GABA (CAS 56-12-2) industry.
Based on our recent survey, we have several different scenarios about the GABA (CAS 56-12-2) YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 47 million in 2019. The market size of GABA (CAS 56-12-2) will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global GABA (CAS 56-12-2) market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global GABA (CAS 56-12-2) market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global GABA (CAS 56-12-2) market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global GABA (CAS 56-12-2) market. The report also includes nautical information, where it shows GABA (CAS 56-12-2) market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global GABA (CAS 56-12-2) market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global GABA (CAS 56-12-2) market.
Gamma-Amino Butyric acid (GABA) is an amino acid which acts as a neurotransmitter in the central nervous system. It inhibits nerve transmission in the brain, calming nervous activity. GABA plays an important role in behavior, cognition, and the body’s response to stress. Lower-than-normal levels of GABA in the brain have been linked to schizophrenia, depression, anxiety, and sleep disorders.
At present, there are two ways to produce GABA: chemical synthesis method and biological fermentation method. Among them, biological fermentation method feeding on monosodium L-glutamate and Lactobacillus, is safer and more widely used. Only in this way, can GABA be used in pharmaceuticals, foods, beverages, and animal feeds in China. The price of GABA produced from monosodium L-glutamate and Lactobacillus is relatively higher. As the limitation of application fields, the market share of chemical synthesis product decreased
Geographical Analysis:
Based on region, the global GABA (CAS 56-12-2) market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global GABA (CAS 56-12-2) market are
Pharma Foods International
Sekisui Chemical
Zhejiang YiWan Biolabs
Shanghai Richen
Guangdong Luckerkong Biotech
Tianjin Shijitianlong Biotech
Ningxiang Jiayuan Biology Technology
Zhejiang Tianrui Chemical
Taizhou Xinyou Pharmaceutical & Chemical
Segment by Type
Chemical Synthesis
Biological Fermentation
Segment by Application
Pharmaceuticals
Food & Beverage
Animal Feeds
Others
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global GABA (CAS 56-12-2) market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global GABA (CAS 56-12-2) market.
• The market share of the global GABA (CAS 56-12-2) market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global GABA (CAS 56-12-2) market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global GABA (CAS 56-12-2) market.
1 GABA (CAS 56-12-2) Market Overview
1.1 GABA (CAS 56-12-2) Product Scope
1.2 GABA (CAS 56-12-2) Segment by Type
1.2.1 Global GABA (CAS 56-12-2) Sales by Type (2020-2026)
1.2.2 Chemical Synthesis
1.2.3 Biological Fermentation
1.3 GABA (CAS 56-12-2) Segment by Application
1.3.1 Global GABA (CAS 56-12-2) Sales Comparison by Application (2020-2026)
1.3.2 Pharmaceuticals
1.3.3 Food & Beverage
1.3.4 Animal Feeds
1.3.5 Others
1.4 GABA (CAS 56-12-2) Market Estimates and Forecasts (2015-2026)
1.4.1 Global GABA (CAS 56-12-2) Sales Growth Rate (2015-2026)
1.4.2 Global GABA (CAS 56-12-2) Revenue and Growth Rate (2015-2026)
1.4.3 Global GABA (CAS 56-12-2) Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): GABA (CAS 56-12-2) Industry Impact
1.5.1 How the Covid-19 is Affecting the GABA (CAS 56-12-2) Industry
1.5.1.1 GABA (CAS 56-12-2) Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and GABA (CAS 56-12-2) Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for GABA (CAS 56-12-2) Players to Combat Covid-19 Impact
2 GABA (CAS 56-12-2) Estimate and Forecast by Region
2.1 Global GABA (CAS 56-12-2) Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global GABA (CAS 56-12-2) Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global GABA (CAS 56-12-2) Sales Market Share by Region (2015-2020)
2.2.2 Global GABA (CAS 56-12-2) Revenue Market Share by Region (2015-2020)
2.3 Global GABA (CAS 56-12-2) Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global GABA (CAS 56-12-2) Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global GABA (CAS 56-12-2) Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States GABA (CAS 56-12-2) Estimates and Projections (2015-2026)
2.4.2 Europe GABA (CAS 56-12-2) Estimates and Projections (2015-2026)
2.4.3 China GABA (CAS 56-12-2) Estimates and Projections (2015-2026)
2.4.4 Japan GABA (CAS 56-12-2) Estimates and Projections (2015-2026)
2.4.5 Southeast Asia GABA (CAS 56-12-2) Estimates and Projections (2015-2026)
2.4.6 India GABA (CAS 56-12-2) Estimates and Projections (2015-2026)
3 Global GABA (CAS 56-12-2) Competition Landscape by Players
3.1 Global Top GABA (CAS 56-12-2) Players by Sales (2015-2020)
3.2 Global Top GABA (CAS 56-12-2) Players by Revenue (2015-2020)
3.3 Global GABA (CAS 56-12-2) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in GABA (CAS 56-12-2) as of 2019)
3.4 Global GABA (CAS 56-12-2) Average Price by Company (2015-2020)
3.5 Manufacturers GABA (CAS 56-12-2) Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key GABA (CAS 56-12-2) Players (Opinion Leaders)
4 Global GABA (CAS 56-12-2) Market Size by Type
4.1 Global GABA (CAS 56-12-2) Historic Market Review by Type (2015-2020)
4.1.1 Global GABA (CAS 56-12-2) Sales Market Share by Type (2015-2020)
4.1.2 Global GABA (CAS 56-12-2) Revenue Market Share by Type (2015-2020)
4.1.3 Global GABA (CAS 56-12-2) Price by Type (2014-2020)
4.2 Global GABA (CAS 56-12-2) Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global GABA (CAS 56-12-2) Sales Forecast by Type (2021-2026)
4.2.2 Global GABA (CAS 56-12-2) Revenue Forecast by Type (2021-2026)
4.2.3 Global GABA (CAS 56-12-2) Price Forecast by Type (2021-2026)
5 Global GABA (CAS 56-12-2) Market Size by Application
5.1 Global GABA (CAS 56-12-2) Historic Market Review by Application (2015-2020)
5.1.1 Global GABA (CAS 56-12-2) Sales Market Share by Application (2015-2020)
5.1.2 Global GABA (CAS 56-12-2) Revenue Market Share by Application (2015-2020)
5.1.3 Global GABA (CAS 56-12-2) Price by Application (2015-2020)
5.2 Global GABA (CAS 56-12-2) Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global GABA (CAS 56-12-2) Sales Forecast by Application (2021-2026)
5.2.2 Global GABA (CAS 56-12-2) Revenue Forecast by Application (2021-2026)
5.2.3 Global GABA (CAS 56-12-2) Price Forecast by Application (2021-2026)
3 North America GABA (CAS 56-12-2) Market Facts & Figures
3.2 North America GABA (CAS 56-12-2) Sales Market Share by Company (2015-2020)
3.3 North America GABA (CAS 56-12-2) Sales Market Share by Type (2015-2020)
3.4 North America GABA (CAS 56-12-2) Sales Market Share by Application (2015-2020)
4 Europe GABA (CAS 56-12-2) Market Facts & Figures
4.2 Europe GABA (CAS 56-12-2) Sales Market Share by Company (2015-2020)
4.3 Europe GABA (CAS 56-12-2) Sales Market Share by Type (2015-2020)
4.4 Europe GABA (CAS 56-12-2) Sales Market Share by Application (2015-2020)
5 China GABA (CAS 56-12-2) Market Facts & Figures
5.2 China GABA (CAS 56-12-2) Sales Market Share by Company (2015-2020)
5.3 China GABA (CAS 56-12-2) Sales Market Share by Type (2015-2020)
5.4 China GABA (CAS 56-12-2) Sales Market Share by Application (2015-2020)
6 Japan GABA (CAS 56-12-2) Market Facts & Figures
6.2 Japan GABA (CAS 56-12-2) Sales Market Share by Company (2015-2020)
6.3 Japan GABA (CAS 56-12-2) Sales Market Share by Type (2015-2020)
6.4 Japan GABA (CAS 56-12-2) Sales Market Share by Application (2015-2020)
7 Southeast Asia GABA (CAS 56-12-2) Market Facts & Figures
7.2 Southeast Asia GABA (CAS 56-12-2) Sales Market Share by Company (2015-2020)
7.3 Southeast Asia GABA (CAS 56-12-2) Sales Market Share by Type (2015-2020)
7.4 Southeast Asia GABA (CAS 56-12-2) Sales Market Share by Application (2015-2020)
8 India GABA (CAS 56-12-2) Market Facts & Figures
8.2 India GABA (CAS 56-12-2) Sales Market Share by Company (2015-2020)
8.3 India GABA (CAS 56-12-2) Sales Market Share by Type (2015-2020)
8.4 India GABA (CAS 56-12-2) Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in GABA (CAS 56-12-2) Business
12.1 Pharma Foods International
12.1.1 Pharma Foods International GABA (CAS 56-12-2) Corporation Information
12.1.2 Pharma Foods International GABA (CAS 56-12-2) Business Overview and Total Revenue
12.1.3 Pharma Foods International GABA (CAS 56-12-2) Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Pharma Foods International GABA (CAS 56-12-2) Products Offered
12.1.5 Pharma Foods International Recent Development
12.2 Sekisui Chemical
12.2.1 Sekisui Chemical GABA (CAS 56-12-2) Corporation Information
12.2.2 Sekisui Chemical GABA (CAS 56-12-2) Business Overview and Total Revenue
12.2.3 Sekisui Chemical GABA (CAS 56-12-2) Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Sekisui Chemical GABA (CAS 56-12-2) Products Offered
12.2.5 Sekisui Chemical Recent Development
12.3 Zhejiang YiWan Biolabs
12.3.1 Zhejiang YiWan Biolabs GABA (CAS 56-12-2) Corporation Information
12.3.2 Zhejiang YiWan Biolabs GABA (CAS 56-12-2) Business Overview and Total Revenue
12.3.3 Zhejiang YiWan Biolabs GABA (CAS 56-12-2) Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Zhejiang YiWan Biolabs GABA (CAS 56-12-2) Products Offered
12.3.5 Zhejiang YiWan Biolabs Recent Development
12.4 Shanghai Richen
12.4.1 Shanghai Richen GABA (CAS 56-12-2) Corporation Information
12.4.2 Shanghai Richen GABA (CAS 56-12-2) Business Overview and Total Revenue
12.4.3 Shanghai Richen GABA (CAS 56-12-2) Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Shanghai Richen GABA (CAS 56-12-2) Products Offered
12.4.5 Shanghai Richen Recent Development
12.5 Guangdong Luckerkong Biotech
12.5.1 Guangdong Luckerkong Biotech GABA (CAS 56-12-2) Corporation Information
12.5.2 Guangdong Luckerkong Biotech GABA (CAS 56-12-2) Business Overview and Total Revenue
12.5.3 Guangdong Luckerkong Biotech GABA (CAS 56-12-2) Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Guangdong Luckerkong Biotech GABA (CAS 56-12-2) Products Offered
12.5.5 Guangdong Luckerkong Biotech Recent Development
12.6 Tianjin Shijitianlong Biotech
12.6.1 Tianjin Shijitianlong Biotech GABA (CAS 56-12-2) Corporation Information
12.6.2 Tianjin Shijitianlong Biotech GABA (CAS 56-12-2) Business Overview and Total Revenue
12.6.3 Tianjin Shijitianlong Biotech GABA (CAS 56-12-2) Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Tianjin Shijitianlong Biotech GABA (CAS 56-12-2) Products Offered
12.6.5 Tianjin Shijitianlong Biotech Recent Development
12.7 Ningxiang Jiayuan Biology Technology
12.7.1 Ningxiang Jiayuan Biology Technology GABA (CAS 56-12-2) Corporation Information
12.7.2 Ningxiang Jiayuan Biology Technology GABA (CAS 56-12-2) Business Overview and Total Revenue
12.7.3 Ningxiang Jiayuan Biology Technology GABA (CAS 56-12-2) Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Ningxiang Jiayuan Biology Technology GABA (CAS 56-12-2) Products Offered
12.7.5 Ningxiang Jiayuan Biology Technology Recent Development
12.8 Zhejiang Tianrui Chemical
12.8.1 Zhejiang Tianrui Chemical GABA (CAS 56-12-2) Corporation Information
12.8.2 Zhejiang Tianrui Chemical GABA (CAS 56-12-2) Business Overview and Total Revenue
12.8.3 Zhejiang Tianrui Chemical GABA (CAS 56-12-2) Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Zhejiang Tianrui Chemical GABA (CAS 56-12-2) Products Offered
12.8.5 Zhejiang Tianrui Chemical Recent Development
12.9 Taizhou Xinyou Pharmaceutical & Chemical
12.9.1 Taizhou Xinyou Pharmaceutical & Chemical GABA (CAS 56-12-2) Corporation Information
12.9.2 Taizhou Xinyou Pharmaceutical & Chemical GABA (CAS 56-12-2) Business Overview and Total Revenue
12.9.3 Taizhou Xinyou Pharmaceutical & Chemical GABA (CAS 56-12-2) Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Taizhou Xinyou Pharmaceutical & Chemical GABA (CAS 56-12-2) Products Offered
12.9.5 Taizhou Xinyou Pharmaceutical & Chemical Recent Development
13 GABA (CAS 56-12-2) Manufacturing Cost Analysis
13.1 GABA (CAS 56-12-2) Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of GABA (CAS 56-12-2)
13.4 GABA (CAS 56-12-2) Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 GABA (CAS 56-12-2) Distributors List
14.3 GABA (CAS 56-12-2) Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global GABA (CAS 56-12-2) Sales (K MT) Growth Rate by Type (2020-2026)
Table 2. Global GABA (CAS 56-12-2) Sales (K MT) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four GABA (CAS 56-12-2) Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for GABA (CAS 56-12-2) Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for GABA (CAS 56-12-2) Players to Combat Covid-19 Impact
Table 8. Global Market GABA (CAS 56-12-2) Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global GABA (CAS 56-12-2) Sales (K MT) by Region (2015-2020)
Table 10. Global GABA (CAS 56-12-2) Sales Market Share by Region (2015-2020)
Table 11. Global GABA (CAS 56-12-2) Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global GABA (CAS 56-12-2) Revenue Share by Region (2015-2020)
Table 13. Global GABA (CAS 56-12-2) Sales (K MT) Forecast by Region (2021-2026)
Table 14. Global GABA (CAS 56-12-2) Sales Market Share Forecast by Region (2021-2026)
Table 15. Global GABA (CAS 56-12-2) Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global GABA (CAS 56-12-2) Revenue Share Forecast by Region (2021-2026)
Table 17. Global GABA (CAS 56-12-2) (K MT) of Key Companies (2015-2020)
Table 18. Global GABA (CAS 56-12-2) Sales Share by Company (2015-2020)
Table 19. Global GABA (CAS 56-12-2) Revenue (US$ Million) by Company (2015-2020)
Table 20. Global GABA (CAS 56-12-2) Revenue Share by Company (2015-2020)
Table 21. Global GABA (CAS 56-12-2) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in GABA (CAS 56-12-2) as of 2019)
Table 22. Global GABA (CAS 56-12-2) Average Price (USD/MT) of Key Company (2015-2020)
Table 23. Manufacturers GABA (CAS 56-12-2) Manufacturing Sites and Area Served
Table 24. Manufacturers GABA (CAS 56-12-2) Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key GABA (CAS 56-12-2) Players
Table 27. Global GABA (CAS 56-12-2) Sales (K MT) by Type (2015-2020)
Table 28. Global GABA (CAS 56-12-2) Sales Share by Type (2015-2020)
Table 29. Global GABA (CAS 56-12-2) Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global GABA (CAS 56-12-2) Price (K MT) by Type (2015-2020)
Table 31. Global GABA (CAS 56-12-2) Sales Share by Type (2021-2026)
Table 32. Global GABA (CAS 56-12-2) Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global GABA (CAS 56-12-2) Revenue Share by Type (2021-2026)
Table 34. Global GABA (CAS 56-12-2) Price (K MT) by Type (2021-2026)
Table 35. Global GABA (CAS 56-12-2) Sales (K MT) by Application (2015-2020)
Table 36. Global GABA (CAS 56-12-2) Sales Share by Application (2015-2020)
Table 37. Global GABA (CAS 56-12-2) Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global GABA (CAS 56-12-2) Price (K MT) by Application (2015-2020)
Table 39. Global GABA (CAS 56-12-2) Sales (K MT) by Application (2021-2026)
Table 40. Global GABA (CAS 56-12-2) Sales Share by Application (2021-2026)
Table 41. Global GABA (CAS 56-12-2) Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global GABA (CAS 56-12-2) Revenue Share by Application (2021-2026)
Table 43. Global GABA (CAS 56-12-2) Price (K MT) by Application (2021-2026)
Table 44. United States GABA (CAS 56-12-2) Sales (K MT) by Company (2015-2020)
Table 45. United States GABA (CAS 56-12-2) Sales Market Share by Company (2015-2020)
Table 46. United States GABA (CAS 56-12-2) Sales (K MT) by Type (2015-2020)
Table 47. United States GABA (CAS 56-12-2) Sales Market Share by Type (2015-2020)
Table 48. United States GABA (CAS 56-12-2) Sales (K MT) by Application (2015-2020)
Table 49. United States GABA (CAS 56-12-2) Sales Market Share by Application (2015-2020)
Table 50. Europe GABA (CAS 56-12-2) Sales (K MT) by Company (2015-2020)
Table 51. Europe GABA (CAS 56-12-2) Sales Market Share by Company (2015-2020)
Table 52. Europe GABA (CAS 56-12-2) Sales (K MT) by Type (2015-2020)
Table 53. Europe GABA (CAS 56-12-2) Sales Market Share by Type (2015-2020)
Table 54. Europe GABA (CAS 56-12-2) Sales (K MT) by Application (2015-2020)
Table 55. Europe GABA (CAS 56-12-2) Sales Market Share by Type (2015-2020)
Table 56. China GABA (CAS 56-12-2) Sales (K MT) by Company (2015-2020)
Table 57. China GABA (CAS 56-12-2) Sales Market Share by Company (2015-2020)
Table 58. China GABA (CAS 56-12-2) Sales (K MT) by Type (2015-2020)
Table 59. China GABA (CAS 56-12-2) Sales Market Share by Type (2015-2020)
Table 60. China GABA (CAS 56-12-2) Sales (K MT) by Application (2015-2020)
Table 61. China GABA (CAS 56-12-2) Sales Market Share by Application (2015-2020)
Table 62. Japan GABA (CAS 56-12-2) Sales (K MT) by Company (2015-2020)
Table 63. Japan GABA (CAS 56-12-2) Sales Market Share by Company (2015-2020)
Table 64. Japan GABA (CAS 56-12-2) Sales (K MT) by Type (2015-2020)
Table 65. Japan GABA (CAS 56-12-2) Sales Market Share by Type (2015-2020)
Table 66. Japan GABA (CAS 56-12-2) Sales (K MT) by Application (2015-2020)
Table 67. Japan GABA (CAS 56-12-2) Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia GABA (CAS 56-12-2) Sales (K MT) by Company (2015-2020)
Table 69. Southeast Asia GABA (CAS 56-12-2) Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia GABA (CAS 56-12-2) Sales (K MT) by Type (2015-2020)
Table 71. Southeast Asia GABA (CAS 56-12-2) Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia GABA (CAS 56-12-2) Sales (K MT) by Type (2015-2020)
Table 73. Southeast Asia GABA (CAS 56-12-2) Sales Market Share by Application (2015-2020)
Table 74. India GABA (CAS 56-12-2) Sales (K MT) by Company (2015-2020)
Table 75. India GABA (CAS 56-12-2) Sales Market Share by Company (2015-2020)
Table 76. India GABA (CAS 56-12-2) Sales (K MT) by Type (2015-2020)
Table 77. India GABA (CAS 56-12-2) Sales Market Share by Type (2015-2020)
Table 78. India GABA (CAS 56-12-2) Sales (K MT) by Application (2015-2020)
Table 79. India GABA (CAS 56-12-2) Sales Market Share by Application (2015-2020)
Table 80. Pharma Foods International Corporation Information
Table 81. Pharma Foods International Description and Business Overview
Table 82. Pharma Foods International GABA (CAS 56-12-2) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Pharma Foods International GABA (CAS 56-12-2) Product
Table 84. Pharma Foods International Recent Development
Table 85. Sekisui Chemical Corporation Information
Table 86. Sekisui Chemical Description and Business Overview
Table 87. Sekisui Chemical GABA (CAS 56-12-2) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Sekisui Chemical GABA (CAS 56-12-2) Product
Table 89. Sekisui Chemical Recent Development
Table 90. Zhejiang YiWan Biolabs Corporation Information
Table 91. Zhejiang YiWan Biolabs Description and Business Overview
Table 92. Zhejiang YiWan Biolabs GABA (CAS 56-12-2) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Zhejiang YiWan Biolabs GABA (CAS 56-12-2) Product
Table 94. Zhejiang YiWan Biolabs Recent Development
Table 95. Shanghai Richen Corporation Information
Table 96. Shanghai Richen Description and Business Overview
Table 97. Shanghai Richen GABA (CAS 56-12-2) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Shanghai Richen GABA (CAS 56-12-2) Product
Table 99. Shanghai Richen Recent Development
Table 100. Guangdong Luckerkong Biotech Corporation Information
Table 101. Guangdong Luckerkong Biotech Description and Business Overview
Table 102. Guangdong Luckerkong Biotech GABA (CAS 56-12-2) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Guangdong Luckerkong Biotech GABA (CAS 56-12-2) Product
Table 104. Guangdong Luckerkong Biotech Recent Development
Table 105. Tianjin Shijitianlong Biotech Corporation Information
Table 106. Tianjin Shijitianlong Biotech Description and Business Overview
Table 107. Tianjin Shijitianlong Biotech GABA (CAS 56-12-2) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Tianjin Shijitianlong Biotech GABA (CAS 56-12-2) Product
Table 109. Tianjin Shijitianlong Biotech Recent Development
Table 110. Ningxiang Jiayuan Biology Technology Corporation Information
Table 111. Ningxiang Jiayuan Biology Technology Description and Business Overview
Table 112. Ningxiang Jiayuan Biology Technology GABA (CAS 56-12-2) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 113. Ningxiang Jiayuan Biology Technology GABA (CAS 56-12-2) Product
Table 114. Ningxiang Jiayuan Biology Technology Recent Development
Table 115. Zhejiang Tianrui Chemical Corporation Information
Table 116. Zhejiang Tianrui Chemical GABA (CAS 56-12-2) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Zhejiang Tianrui Chemical Description and Business Overview
Table 118. Zhejiang Tianrui Chemical GABA (CAS 56-12-2) Product
Table 119. Zhejiang Tianrui Chemical Recent Development
Table . Taizhou Xinyou Pharmaceutical & Chemical Corporation Information
Table . Taizhou Xinyou Pharmaceutical & Chemical GABA (CAS 56-12-2) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table . Taizhou Xinyou Pharmaceutical & Chemical Description and Business Overview
Table . Taizhou Xinyou Pharmaceutical & Chemical GABA (CAS 56-12-2) Product
Table . Taizhou Xinyou Pharmaceutical & Chemical Recent Development
Table 125. Production Base and Market Concentration Rate of Raw Material
Table 126. Key Suppliers of Raw Materials
Table 127. GABA (CAS 56-12-2) Distributors List
Table 128. GABA (CAS 56-12-2) Customers List
Table 129. Market Key Trends
Table 130. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 131. Key Challenges
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. GABA (CAS 56-12-2) Product Picture
Figure 2. Global GABA (CAS 56-12-2) Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global GABA (CAS 56-12-2) Market Share by Application in 2020 & 2026
Figure 6. Pharmaceuticals Examples
Figure 7. Food & Beverage Examples
Figure 8. Animal Feeds Examples
Figure 9. Others Examples
Figure 10. Global GABA (CAS 56-12-2) Sales (K MT) Growth Rate (2015-2026)
Figure 11. Global GABA (CAS 56-12-2) Revenue (US$ Million) Growth Rate (2015-2026)
Figure 12. Global GABA (CAS 56-12-2) Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 13. Global GABA (CAS 56-12-2) Revenue Market Share by Region: 2015 VS 2020
Figure 14. Global GABA (CAS 56-12-2) Revenue Market Share by Region: 2021 VS 2026
Figure 15. United States GABA (CAS 56-12-2) Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. United States GABA (CAS 56-12-2) Sales (K MT) Growth Rate (2015-2026)
Figure 17. Europe GABA (CAS 56-12-2) Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. Europe GABA (CAS 56-12-2) Sales (Million USD) Growth Rate (2015-2026)
Figure 19. China GABA (CAS 56-12-2) Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. China GABA (CAS 56-12-2) Sales (Million USD) and Growth Rate (2015-2026)
Figure 21. Japan GABA (CAS 56-12-2) Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Japan GABA (CAS 56-12-2) Sales (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia GABA (CAS 56-12-2) Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia GABA (CAS 56-12-2) Sales (Million USD) Growth Rate (2015-2026)
Figure 25. India GABA (CAS 56-12-2) Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. India GABA (CAS 56-12-2) Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Global 5 Largest GABA (CAS 56-12-2) Players Market Share by Revenue in GABA (CAS 56-12-2) 2015 & 2019
Figure 28. GABA (CAS 56-12-2) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global GABA (CAS 56-12-2) Revenue Share by Type (2015-2020)
Figure 30. Global GABA (CAS 56-12-2) Revenue Growth Rate by Type in 2015 & 2019
Figure 31. Global GABA (CAS 56-12-2) Revenue Share by Application (2015-2020)
Figure 32. Global GABA (CAS 56-12-2) Revenue Growth Rate by Application in 2015 & 2019
Figure 33. United States GABA (CAS 56-12-2) Sales Market Share by Type in 2019
Figure 34. United States GABA (CAS 56-12-2) Sales Market Share by Type in 2019
Figure 35. Europe GABA (CAS 56-12-2) Sales Market Share by Company in 2019
Figure 36. Europe GABA (CAS 56-12-2) Sales Market Share by Type in 2019
Figure 37. Europe GABA (CAS 56-12-2) Sales Market Share by Application in 2019
Figure 38. China GABA (CAS 56-12-2) Sales Market Share by Company in 2019
Figure 39. China GABA (CAS 56-12-2) Sales Market Share by Type in 2019
Figure 40. China GABA (CAS 56-12-2) Sales Market Share by Application in 2019
Figure 41. Japan GABA (CAS 56-12-2) Sales Market Share by Company in 2019
Figure 42. Japan GABA (CAS 56-12-2) Sales Market Share by Type in 2019
Figure 43. Japan GABA (CAS 56-12-2) Sales Market Share by Application in 2019
Figure 44. Southeast Asia GABA (CAS 56-12-2) Sales Market Share by Company in 2019
Figure 45. Southeast Asia GABA (CAS 56-12-2) Sales Market Share by Type in 2019
Figure 46. Southeast Asia GABA (CAS 56-12-2) Sales Market Share by Application in 2019
Figure 47. India GABA (CAS 56-12-2) Sales Market Share by Company in 2019
Figure 48. India GABA (CAS 56-12-2) Sales Market Share by Type in 2019
Figure 49. India GABA (CAS 56-12-2) Sales Market Share by Application in 2019
Figure 50. Pharma Foods International Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Sekisui Chemical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Zhejiang YiWan Biolabs Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Shanghai Richen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Guangdong Luckerkong Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Tianjin Shijitianlong Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Ningxiang Jiayuan Biology Technology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Zhejiang Tianrui Chemical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Taizhou Xinyou Pharmaceutical & Chemical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Key Raw Materials Price Trend
Figure 60. Manufacturing Cost Structure of GABA (CAS 56-12-2)
Figure 61. Manufacturing Process Analysis of GABA (CAS 56-12-2)
Figure 62. GABA (CAS 56-12-2) Industrial Chain Analysis
Figure 63. Channels of Distribution
Figure 64. Distributors Profiles
Figure 65. Porter's Five Forces Analysis
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed